Timothy Warbington - Creative Medical President CEO, Director
CELZ Stock | USD 2.44 0.13 5.63% |
CEO
Mr. Timothy Warbington is President, Chief Executive Officer, Director of the Company. Mr. Warbington has served as a director and as Chief Executive Officer of CMT since February 2016 and has served as a director, Chief Executive Officer and President of Creative Medical Health since October 2011. He has over 25 years of executive level management experience since 2016.
Age | 63 |
Tenure | 9 years |
Address | 211 East Osborn Road, Phoenix, AZ, United States, 85012 |
Phone | (480) 399-2822 |
Web | https://www.creativemedicaltechnology.com |
Latest Insider Transactions
Warbington received a Bachelor’s Degree in Accounting from Arizona State University in 1984. From 1993 through 2007 he owned and operated a multimillion dollar national agricultural . Prior to that, he served as Chief Operating Officer of the U.S. subsidiary of a British firm engaged in the international food trade. For eight years, Mr. Warbington has invested in the biotechnology industry and has provided strategic and tactical advice as a consultant to a publically traded biotech firm. In connection with this experience, he has built a network of scientists, physicians and executives to participate as executive officers and directors of Creative Medical Health.Timothy Warbington Latest Insider Activity
Tracking and analyzing the buying and selling activities of Timothy Warbington against Creative Medical stock is an integral part of due diligence when investing in Creative Medical. Timothy Warbington insider activity provides valuable insight into whether Creative Medical is net buyers or sellers over its current business cycle. Note, Creative Medical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Creative Medical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Timothy Warbington over three months ago Acquisition by Timothy Warbington of 20000 shares of Creative Medical at 0.605 subject to Rule 16b-3 | ||
Timothy Warbington over six months ago Acquisition by Timothy Warbington of 9800 shares of Creative Medical at 0. subject to Rule 16b-3 | ||
Timothy Warbington over six months ago Acquisition by Timothy Warbington of 500000000 shares of Creative Medical at 1.0E-4 subject to Rule 16b-3 | ||
Timothy Warbington over a year ago Purchase by Timothy Warbington of 300 shares of Creative Medical |
Creative Medical Management Efficiency
The company has return on total asset (ROA) of (0.3627) % which means that it has lost $0.3627 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5703) %, meaning that it created substantial loss on money invested by shareholders. Creative Medical's management efficiency ratios could be used to measure how well Creative Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.62 in 2025. Return On Capital Employed is likely to drop to -0.51 in 2025. At this time, Creative Medical's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 12.4 M in 2025, whereas Non Current Assets Total are likely to drop slightly above 401.4 K in 2025.Similar Executives
Found 2 records | CEO Age | ||
J Finley | Palisade Bio | 68 | |
Eric Schlorff | LMF Acquisition Opportunities | 52 |
Management Performance
Return On Equity | -0.57 | ||||
Return On Asset | -0.36 |
Creative Medical Tec Management Team
Elected by the shareholders, the Creative Medical's board of directors comprises two types of representatives: Creative Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Creative. The board's role is to monitor Creative Medical's management team and ensure that shareholders' interests are well served. Creative Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Creative Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Donald Dickerson, CFO, Senior Vice President Director | ||
Timothy Warbington, President CEO, Director | ||
Donald MBA, CFO VP |
Creative Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Creative Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.57 | ||||
Return On Asset | -0.36 | ||||
Operating Margin | (511.82) % | ||||
Current Valuation | (2 M) | ||||
Shares Outstanding | 1.75 M | ||||
Shares Owned By Insiders | 2.10 % | ||||
Shares Owned By Institutions | 4.53 % | ||||
Number Of Shares Shorted | 25.31 K | ||||
Price To Earning | (54.81) X | ||||
Price To Book | 0.65 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.BTC | Bitcoin | |
TRX | TRON | |
BNB | Binance Coin |
Additional Tools for Creative Stock Analysis
When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.